Baird, J., Louisa, M., Noviyanti, R., Ekawati, L., Elyazar, I., Subekti, D., . . . Setiabudy, R. (2018). Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria. American Medical Association.
Chicago Style (17th ed.) CitationBaird, JK, et al. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype with Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium Vivax Malaria. American Medical Association, 2018.
MLA引文Baird, JK, et al. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype with Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium Vivax Malaria. American Medical Association, 2018.